Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Journal of Comprehensive Pediatrics

homeHome
check_circleAccepted Manuscriptsplay_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteespublicIndexing and Listing SourcesbalancePublication Ethics and Publication Malpractice StatementemailSupportshow_chartJournal Metricsassignment_indReviewer and AE Registration FormphoneContact Uszoom_inOpen Peer Review (OPR)
view_listAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Effect of vitamin e on cardiometabolic factors in paediatric metabolic dysfunction-associated steatotic liver disease: A systematic review with meta-analysis

- Pam P. , et al.

2. Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis

- Yaser S. , et al.

3. The Role of Metformin in Modifying Ferroptosis to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: A Narrative Review

- Sotoudeheian M. , et al.

4. Effects of metformin on anthropometric indices and hormones and adipocytokine concentrations in children with overweight or obesity: a systematic review and meta-analysis of randomised controlled trials

- Theodoridis X. , et al.

5. Effectiveness of pharmacological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline

- Wahi G. , et al.

6. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

- Gkiourtzis N. , et al.

7. PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis

- Zhang Z.Y. , et al.